GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

COVID-19 was associated with more severe disease outcomes than influenza or respiratory syncytial virus (RSV) during the 2022 to 2023 season.

Research reveals that even low levels of air pollution significantly increase the risk of respiratory infections in adults, ...

Around the new year, many people set goals for better health. People ages 65 and older can kick off a healthy new year by getting vaccinated for flu, COVID-19 and RSV. These respiratory infections can ...

The virus is a common respiratory illness that infects the lungs and airways. Most people experience mild symptoms, like the common cold. However, RSV can cause more severe symptoms in infants, older ...

For the week ending Jan. 25, seasonal flu activity remains high and increasing. Clinical laboratories tested 129,378 ...

During the COVID pandemic, RSV showed a slightly odd pattern: like flu, it basically disappeared in the 2020–2021 season, ...

One Zelienople child survived a serious health scare after coming down with respiratory syncytial virus in late January. The ...

After a short reprieve earlier this month, respiratory illness levels have again moved from moderate to high in Illinois, with the flu driving much of the increase, according to the state health ...

For years, healthy older adults were advised by doctors to take a low-dose aspirin daily as a way to reduce the risk of heart ...

The four named viruses, which some have deemed a 'quad-demic,' consist of RSV, COVID-19, influenza, and norovirus. Dr. Abinash Achrekar, KOAT and University of New Mexico health expert, explains what ...